首页> 外文期刊>Naunyn-Schmiedeberg's Archives of Pharmacology >Cardiomyocyte Ca2+ overload in atrial tachycardia: is blockade of L-type Ca2+ channels a promising approach to prevent electrical remodeling and arrhythmogenesis?
【24h】

Cardiomyocyte Ca2+ overload in atrial tachycardia: is blockade of L-type Ca2+ channels a promising approach to prevent electrical remodeling and arrhythmogenesis?

机译:房性心动过速中心肌细胞Ca2 + 超负荷:阻断L型Ca2 + 通道是否是防止电重构和心律失常的有前途的方法?

获取原文
获取原文并翻译 | 示例
           

摘要

Electrical remodeling paradigm has important implications for the understanding of atrial fibrillation (AF) and improvement of current treatment. Cardiomyocyte Ca2+ overload is generally accepted as the initiating signal for the tachycardia-induced changes in atrial electrical properties (electrical remodeling). The precise role of cardiomyocyte Ca2+ overload in AF-related ion channel alterations that contribute to AF maintenance is not fully understood. Clinically, patients with AF are often treated with Ca2+ channel blockers such as verapamil to control their ventricular rate and to improve the success rate of cardioversion procedures. However, verapamil may produce an increased L-type Ca2+ channel current (ICa,L) that may reinforce Ca2+ overload thereby promoting AF in the atrium. Ca2+ channel blockers which target T-type Ca2+ channels in addition to ICa,L (for instance, efonidipine) may be more efficient at preventing Ca2+ overload and arrhythmogenic electrical remodeling, but the potential benefits of these drugs have usually been tested in experimental models where drug administration preceded the initiation of electrical remodeling. Studies in animal models with established atrial tachycardia remodeling and in patients with AF are clearly warranted to prove the efficacy of Ca2+ channel blockers that additionally target T-type Ca2+ channels.
机译:电气重塑范例对了解房颤(AF)和改善当前治疗方法具有重要意义。心肌细胞Ca2 + 超载通常被认为是心动过速引起的房性电特性变化(电重构)的起始信号。心肌细胞Ca2 +超负荷在与AF相关的离子通道改变中对AF维持有贡献的确切作用尚不完全清楚。在临床上,房颤患者通常使用Ca2 +通道阻滞剂(如维拉帕米)治疗,以控制其心室率并提高心脏复律手术的成功率。然而,维拉帕米可能会产生增加的L型Ca2 +通道电流(ICa,L ),这可能会增强Ca2 + 的过载,从而促进心房房颤。除ICa,L 外,还针对T型Ca2 + 通道的Ca2 + 通道阻滞剂(例如依氟地平)可能更有效地防止Ca2 + 过载和心律失常性电重构,但是这些药物的潜在益处通常已经在实验模型中进行了测试,在实验模型中,在进行电重构之前先进行药物给药。明确需要对已建立心房性心动过速重塑的动物模型以及房颤患者进行研究,以证明另外以T型Ca2 + 通道为靶点的Ca2 + 通道阻滞剂的疗效。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号